Laboratory of Veterinary Pharmacology, School of Veterinary Medicine, Kitasato University, Aomori 034-8628, Japan.
J Pharmacol Sci. 2012;120(1):26-35. doi: 10.1254/jphs.12088fp. Epub 2012 Aug 23.
Methylglyoxal (MGO) is a metabolite of glucose and perhaps mediates diabetes-related macrovascular complications including hypertension. In the present study, we examined if MGO accumulation affects vascular reactivity of isolated mesenteric artery from spontaneously hypertensive rats (SHR). Five-week-old SHR were treated with an MGO scavenger, aminoguanidine (AG), for 5 weeks. AG partially normalized increased blood pressure in SHR. In mesenteric artery from SHR treated with AG, increased accumulation of MGO-derived advanced glycation end-products was reversed. In mesenteric artery from SHR, AG normalized impaired acetylcholine (ACh)-induced relaxation and increased angiotensin (Ang) II-induced contraction. Reactive oxygen species (ROS) production increased in SHR mesenteric artery, and acute treatment with a nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) inhibitor augmented ACh-induced relaxation. Protein expression of NOX1 and Ang II type 2 receptor (AT2R) increased in SHR mesenteric artery, which was normalized by AG. Acute treatment with an AT2R blocker but not a NOX inhibitor normalized the increased Ang II-induced contraction in SHR mesenteric artery. The present results demonstrate that MGO accumulation in mesenteric artery may mediate development of hypertension in SHR at least in part via increased ROS-mediated impairment of endothelium-dependent relaxation and AT2R-mediated increased Ang II contraction.
甲基乙二醛(MGO)是葡萄糖的代谢产物,可能介导包括高血压在内的与糖尿病相关的大血管并发症。在本研究中,我们研究了 MGO 积累是否会影响自发性高血压大鼠(SHR)离体肠系膜动脉的血管反应性。5 周龄的 SHR 用 MGO 清除剂氨基胍(AG)治疗 5 周。AG 部分纠正了 SHR 的血压升高。在接受 AG 治疗的 SHR 肠系膜动脉中,MGO 衍生的晚期糖基化终产物的积累增加得到逆转。在 SHR 肠系膜动脉中,AG 使乙酰胆碱(ACh)诱导的舒张受损和血管紧张素(Ang)II 诱导的收缩增加得到正常化。SHR 肠系膜动脉中活性氧(ROS)产生增加,烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶(NOX)抑制剂的急性处理增强了 ACh 诱导的舒张。SHR 肠系膜动脉中 NOX1 和 Ang II 型 2 型受体(AT2R)的蛋白表达增加,AG 使其正常化。急性使用 AT2R 阻滞剂而不是 NOX 抑制剂可使 SHR 肠系膜动脉中增加的 Ang II 诱导的收缩正常化。本研究结果表明,MGO 在肠系膜动脉中的积累可能至少部分通过增加 ROS 介导的内皮依赖性舒张受损和 AT2R 介导的 Ang II 收缩增加来介导 SHR 高血压的发展。